COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 2246: Articles 22451-22460  | Next

Development and calibration of a simple mortality risk score for hospitalized COVID-19 adults
Yoo, E., Percha, B., Tomlinson, M., Razuk, V., Pan, S., Basist, M., Tandon, P., Wang, J. G., Gao, C., Bose, S., Gidwani, U. K.
10.1101/2020.08.31.20185363 — Posted: 2020-09-02
Determinants of SARS-CoV-2 receptor gene expression in upper and lower airways
Aliee, H., Massip, F., Qi, C., Stella de Biase, M., van Nijnatten, J. L., Kersten, E. T. G., Kermani, N. Z., Khuder, B., Vonk, J. M., Vermeulen, R. C. H., U-BIOPRED study group, , Cambridge Lung Cancer Early Detection Programme, , INER-Ciencias Mexican Lung Program, , NHLBI LungMAP Consortium, , Neighbors, M., Tew, G. W., Grimbaldeston, M., ten Hacken, N. H. T., Hu, S., Guo, Y., Zhang, X., Sun, K., Hiemstra, P. S., Ponder, B. A., Makela, M. J., Malmstrom, K., Rintoul, R. C., Reyfman, P. A., Theis, F. J., Brandsma, C.-A., Adcock, I., Timens, W., Xu, C. J., van den Berge, M., Schwarz, R. F., Koppelman, G. H., Nawijn, M. C., Faiz, A.
10.1101/2020.08.31.20169946 — Posted: 2020-09-02
Trust and Transparency in times of Crisis: Results from an Online Survey During the First Wave (April 2020) of the COVID-19 Epidemic in the UK
Enria, L., Waterlow, N., Rogers, N. T., Brindle, H., Lal, S., Eggo, R. M., Lees, S., Roberts, C. h.
10.1101/2020.09.01.20183822 — Posted: 2020-09-02
Community pharmacists' knowledge and preparedness to participate in the fight against Coronavirus disease 2019 (COVID-19) in Zambia
Hangoma, J. M., Mudenda, S., Mwenechanya, M. M., Kalungia, A. C.
10.1101/2020.09.01.20185694 — Posted: 2020-09-02
Mental healthcare and service user impact of the COVID-19 pandemic: results of a UK survey of staff working with people with intellectual disability and developmental disorders
Sheehan, R., Dalton-Locke, C., Ali, A., Totsika, V., Vera San Juan, N., Hassiotis, A.
10.1101/2020.09.01.20178848 — Posted: 2020-09-02
Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19.
Bramante, C., Tignanelli, C. J., Dutta, N., Jones, E., Tamariz, L., Clark, J. M., Usher, M., Metlon-Meaux, G., Ikramuddin, S.
10.1101/2020.09.01.20185850 — Posted: 2020-09-02 Discussion: Offsite
Estimation of a state of Corona 19 epidemic in August 2020 by multistage logistic model: a case of EU, USA, and World
batista, m.
10.1101/2020.08.31.20185165 — Posted: 2020-09-02
Assessing the Impact of the Covid-19 Pandemic on US Mortality: A County-Level Analysis
Stokes, A. C., Lundberg, D. J., Hempstead, K., Elo, I. T., Preston, S. H.
10.1101/2020.08.31.20184036 — Posted: 2020-09-02
Social multipliers and the Covid-19 epidemic: Analysis through constrained maximum entropy modeling
Foley, D. K.
10.1101/2020.09.01.20185868 — Posted: 2020-09-02
Covid-19 SEIDRD Modelling for Pakistan with implementation of seasonality, healthcare capacity and behavioral risk reduction
Saadat, S., Mansoor, S., Fahim, A.
10.1101/2020.09.01.20182642 — Posted: 2020-09-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).